Bring back August

Discussion in 'Acorda Therapeutics' started by anonymous, Aug 17, 2019 at 9:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    We MUST bring back Augusto. He knows Medical Affairs better than none other. He can rescue Acorda and bring back the days of over $ 30 bucks a share.

    Why are we wasting time with Mr Blank, when we can bring back a true professional in drug development to build our pipeline?!
     

  2. anonymous

    anonymous Guest

    Too late... the old saying “ you live with what you launch.” All trajectories have been set , and the market did not like what it saw, and punished. Additionally, set an ill perception with the street of Acorda ability to effectively launch a product. Digest the failure and move on... your on nobodys radar.
     
  3. anonymous

    anonymous Guest

    No way, you will see how the Acorda Team makes Inbrija a household Brand, as well-known as Tylenol. Wait, See & Learn from the Masters. They did it once before with Ampyra.

    And no need to bring any of those Mexicans. All they did was speak Spanish, drink coffee and dance Salsa. We DID send them BACK!!!!!!!!!!!!!!!!!!
     
  4. anonymous

    anonymous Guest

    The talent that launched Ampyra has left the building... your now stuck with leftovers that botched this launch. And yes, you will become a household name as one of the worst performing stocks of 2019 and 2018.
     
  5. anonymous

    anonymous Guest

    We are already on the rebound !!!

    ACOR is going to be a gold mine, but you must be patient as the market for Inbrija will grow slow at first and then grow exponentially !! Literally explode as the international market accepts it !

    We have plenty of talent left in the 'building'. We have a strong C-Suite and a hard working field team !!
     
  6. anonymous

    anonymous Guest

    ACOR is a strong sell. Dump it now.
     
  7. anonymous

    anonymous Guest

    Call him all the names you want... your company and stock still sucks. Your leadership misled you. Your equity you received as an employee has been stripped to nothing... essentially your leadership pulled $$ out of your pocket.... not the previous poster.
     
  8. anonymous

    anonymous Guest

    This 5 year chart hardly looks like a rebound... look like a dive into the bowels of Wall Street :
     
  9. anonymous

    anonymous Guest



    You obviously not familiar with Elliott Wave and Keynesian economic model re the inflection point and long term strategy to enrich shareholders. YES we are on cusp of some big rebounds. Target price upped to 19 !!

    SO be patient my friend. If you are spineless then do not invest any further, just watch from the peanut gallery. If you are of strong constitution consider some buy in !! and GO GO GO !!!!!!!
     
  10. anonymous

    anonymous Guest

    Your tried this Elliot wave BS back when you were at 7-8.... don’t be a blind fool... you sound like an ingnoramus.

    Even if you triple your current price you are still at a 3 year low. Hang it up... you guys sound like your in a cult.

    Fact is many investors lost big and lost interest in you, the only thing you will attract is an unsolicited buyout for the IP, and a real Pharma company will launch this product.
     
  11. anonymous

    anonymous Guest

    There is a course on this at Harvard Business School, so it is not BS. Maybe too statistical for the average guy.
     
  12. anonymous

    anonymous Guest

    Yes, but does not fit this poor example.Folks trying to rally a buy, when hey should be busting their ass working on the business.
     
  13. anonymous

    anonymous Guest

    Habib, Harvard also has courses on leadership and effective management.

    The one thing they all have in common is that none apply to ACOR.
     
  14. anonymous

    anonymous Guest

    Acorda rocks !
    We are champions !
    We will bridge to success !
    Inbrija will bust balls !